YAG
MDCX

Yorkville Advisors Global’s Medicus Pharma MDCX Stock Holding History

Yorkville Advisors Global’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-230,000
Closed -$532K – 44
2025
Q3 		$532K Buy
230,000
+124,160
+117% +$311K 0.21% 17
2025
Q2 		$316K Buy
+105,840
New +$423K 0.09% 14

Other funds holding MDCX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Yorkville Advisors Global's MDCX Position: Q4 2025 in Review

Yorkville Advisors Global sold out of Medicus Pharma (MDCX) in Q4 2025, closing a stake of 230,000 shares — an estimated $532K sold.

Yorkville Advisors Global first reported a position in MDCX in Q2 2025 and held it in 2 quarters. The position peaked at $532K in Q3 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q4 2025.

  • Yorkville Advisors Global reported no remaining Medicus Pharma position as of Q4 2025 after selling out during the quarter.
  • Yorkville Advisors Global sold 230,000 Medicus Pharma shares in Q4 2025, an estimated $532K.
  • Yorkville Advisors Global first reported a position in Medicus Pharma in Q2 2025 and held it in 2 quarters.
  • Yorkville Advisors Global's Medicus Pharma position peaked at $532K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q4 2025.

Based on Yorkville Advisors Global's 13F filing for Q4 2025, filed 10 Feb 2026.